Research and Development

The EMA has granted Takeda an accelerated assessment for its multiple myeloma drug, ixazomib. The Agency’s Committee for Medicinal Products …

Sanofi Pasteur and Merck have appointed David Khougazian as president of their joint company, Sanofi Pasteur MSD. David Khougazian joined …

Dr James Shannon has joined Immodulon as a non-executive director with immediate effect. Bringing with him 30 years’ of experience …

Two drugs that pharma companies are pinning hopes on for future success have had mixed outcomes in key late-stage clinical …

Novartis has formed a new UK biotech company by selling three investigational drugs in exchange for shares in the new …

A new consortium has been launched to act as a ‘match-making’ service between pharma companies and R&D researchers to develop …

Both sides of a bitterly contested legal battle over a major part of the industry’s transparency drive have reacted to …

A judge has ruled that there are likely to be no legal grounds to block the Health Research Authority’s plans …

Pharma giants Sanofi and Regeneron are extending the partnership that brought new heart drug Praluent to the market, with a …

Antibiotic-resistant infections gather more headlines than most other infectious disease topics, and have typically been seen as a neglected area …

GSK has taken a significant step forward toward being the first company to bring a malaria vaccine to market, after …

The European Medicines Agency has relaxed some of its rules around the development of drugs in children, in order to …

Big pharma companies have posted mixed results in trials of several potential new treatments for Alzheimer’s disease. But the results, …

Bristol-Myers Squibb has stopped its Phase III study of its immunotherapy drug Opdivo in people with kidney cancer early after …

NICE will oversee the evaluation of Cancer Drugs Fund treatments in future, under new plans due for consultation by NHS …